切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2021, Vol. 15 ›› Issue (03) : 200 -204. doi: 10.3877/cma.j.issn.1674-0785.2021.03.009

临床研究

综合干预策略对老年稳定期慢性阻塞性肺疾病患者肺功能及生活状态的影响
孔苗苗1, 杨娟1, 朱慕云1,()   
  1. 1. 225001 江苏扬州,扬州大学临床医学院
  • 收稿日期:2020-09-01 出版日期:2021-03-15
  • 通信作者: 朱慕云

Influence of comprehensive intervention strategies on pulmonary function and life status of elderly patients with stable chronic obstructive pulmonary disease

Miaomiao Kong1, Juan Yang1, Muyun Zhu1,()   

  1. 1. Yangzhou University Medicine College, Yangzhou 225001, China
  • Received:2020-09-01 Published:2021-03-15
  • Corresponding author: Muyun Zhu
引用本文:

孔苗苗, 杨娟, 朱慕云. 综合干预策略对老年稳定期慢性阻塞性肺疾病患者肺功能及生活状态的影响[J/OL]. 中华临床医师杂志(电子版), 2021, 15(03): 200-204.

Miaomiao Kong, Juan Yang, Muyun Zhu. Influence of comprehensive intervention strategies on pulmonary function and life status of elderly patients with stable chronic obstructive pulmonary disease[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(03): 200-204.

目的

研究综合干预策略对老年稳定期慢性阻塞性肺疾病(COPD)患者肺功能及生活状态的影响。

方法

选择2018年12月至2019年12月在本院就诊的120例老年稳定期COPD患者,根据患者干预意愿分成对照组和观察组,每组各60例。对照组予以止咳化痰、解痉平喘等对症治疗,观察组在对症治疗基础之上予以综合干预策略。分别在干预后第1、3、6个月随访,观察2组患者营养状况(MNA)、日常生活能力(ADL)、衰弱状况(MFS)及肺功能的改变。

结果

观察组患者干预前和干预后1、3、6个月的MNA评分分别为(20.48±0.83)、(21.81±1.28)、(23.39±1.03)、(24.32±0.91)分,干预后6个月与干预前比较差异具有统计学意义(P<0.05),且观察组患者干预后MNA评分均较对照组明显升高(P<0.05)。观察组患者干预前和干预后1、3、6个月的ADL评分分别为(68.50±5.77)、(73.20±5.60)、(85.00±7.07)、(89.58±6.20)分,干预后6个月与干预前比较差异具有统计学意义(P<0.05),且观察组患者干预后ADL评分均较对照组明显升高(P<0.05)。观察组患者干预前和干预后1、3、6个月的MFS评分分别为(38.67±7.97)、(32.75±0.96)、(26.33±8.78)、(18.17±9.61)分,干预后6个月与干预前比较差异具有统计学意义(P<0.05),且观察组患者干预后MFS评分均较对照组明显下降(P<0.05)。干预后2组患者FVC值均有轻微升高,但2组相比差异无统计学意义(P>0.05),观察组患者FEV1由干预前(2.46±0.45)L改善为干预后(2.84±0.26)L,FEV1%由干预前(57.68±12.73)%改善为干预后(77.05±5.92)%,差异具有统计学意义(P均<0.05)。

结论

综合干预可显著改善老年稳定期COPD患者肺功能水平、日常生活能力、衰弱及营养状况,从而改善患者的生活状态。

Objective

To study the effect of comprehensive intervention strategies on pulmonary function and life status of elderly patients with stable chronic obstructive pulmonary disease (COPD).

Methods

A total of 120 elderly patients with stable COPD who were treated at our hospital from December 2018 to December 2019 were divided into either an observation group or a control group according to the patients' willingness, with 60 cases in each group. Patients in both groups were given basic treatments such as relieving cough, phlegm, tracheal spasm, and asthma, and patients in the observation group were additionally given comprehensive intervention strategies. The patients were followed at 1, 3, and 6 months after intervention to observe the changes in nutritional status, the ability of daily life, the weakness status, and the pulmonary function.

Results

The MNA scores of patients in the observation group at 1, 3, and 6 months after intervention were 21.81±1.28, 23.39±1.03, and 24.32±0.91, respectively, which were significantly higher than that before intervention (20.48±0.83) (P<0.05) and those in the control group after intervention (P<0.05).The ADL scores of patients in the observation group at 1, 3, and 6 months after intervention were 73.20±5.60, 85.00±7.07, and 89.58±6.20, respectively, which were significantly higher than that before intervention (68.50±5.77) (P<0.05) and those in the control group after intervention (P<0.05). The MFS scores of patients in the observation group at 1, 3, and 6 months after intervention were 32.75±0.96, 26.33±8.78, and 18.17±9.61, respectively, which were significantly lower than that before intervention (38.67±7.97) (P<0.05) and those in the control group after intervention (P<0.05). After the intervention, the FVC value increased slightly in both groups, and the difference between the two groups was not statistically significant (P>0.05). The FEV1 in the observation group improved from (2.46±0.45) L before intervention to (2.84±0.26) L after management , and FEV1% improved from (57.68±12.73)% before intervention to (77.05±5.92)% after management, the differences were statistically significant (P<0.05).

Conclusion

Comprehensive intervention strategies can significantly improve the pulmonary function, the ability of daily living, and the frailty and nutritional status of patients with stable COPD, thus improving their life status.

表1 2组老年稳定期慢性阻塞性肺疾病患者干预前后营养状况评分比较(分,
xˉ
±s
表2 2组老年稳定期慢性阻塞性肺疾病患者干预前后日常生活能力评分比较(分,
xˉ
±s
表3 2组老年稳定期慢性阻塞性肺疾病患者干预前后跌倒风险评分比较(分,
xˉ
±s
表4 2组老年稳定期慢性阻塞性肺疾病患者干预前后肺功能情况比较(
xˉ
±s
1
叶志鹏, 陈磊. 慢性阻塞性肺疾病合并焦虑抑郁的研究进展 [J]. 中国呼吸与危重监护杂志, 2019, 18(5): 491-494.
2
Kennedy CC, Novotny PJ, LeBrasseur NK, et al. Frailty and clinical outcomes in chronic obstructive pulmonary disease [J]. Ann Am Thorac Soc, 2019, 16(2): 217-224.
3
陈亚红. 2018年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读 [J/OL]. 中国医学前沿杂志(电子版), 2017, 9(12): 15-22.
4
杨娟, 朱慕云. 吸气肌群功能康复在慢阻肺患者康复治疗中的作用 [J]. 临床肺科杂志, 2018, 23(9): 1716-1719.
5
孔苗苗, 杨娟, 朱慕云. 激励式呼吸肌功能训练对稳定期老年慢阻肺患者肺功能及生活能力的影响 [J]. 中国现代医药杂志, 2020, 22(11): 89-91.
6
杨琤瑜, 金美玲, 朱惠莉. 慢性阻塞性肺疾病营养状态及营养支持的研究进展 [J]. 国际呼吸杂志, 2018, 38(16): 1265-1268.
7
Lahousse L, Ziere G, Verlinden VJ, et al. Risk of frailty in elderly with COPD: A population-based study [J]. J Gerontol A Biol Sci Med Sci, 2016, 71(5): 689-695.
8
张艳汝. 老年综合评估在慢性阻塞性肺疾病治疗中的应用 [J/OL]. 中华老年病研究电子杂志, 2018, 5(4): 20-24.
9
杨丹, 张练, 李嫚, 等. 抗阻呼吸训练对COPD患者肺康复及生活质量的影响[J]. 中华现代护理杂志, 2018, 24(29): 3552-3556.
10
Sanchez-Morillo D, Lara-Dona A, Priego-Torres B, et al. Portable oxygen therapy: Is the 6-minute walking test overestimating the actual oxygen needs? [J]. J Clin Med, 2020, 9(12): 4007-4019.
11
Hogan D, Lan LT, Diep DT, et al. Nutritional status of Vietnamese outpatients with chronic obstructive pulmonary disease [J]. J Hum Nutr Diet, 2017, 30(1): 83-89.
12
Broekhuizen R, Creutzberg EC, Weling-Scheepers CA, et al. Optimizing oral nutritional drink supplementation in patients with chronic obstructive pulmonary disease [J]. Br J Nutr, 2005, 93(6): 965-971.
13
Tekerlek H, Cakmak A, Calik-Kutukcu E, et al. Exercise capacity and activities of daily living are related in patients with chronic obstructive pulmonary disease [J]. Arch Bronconeumol, 2020, 56(4): 208-213.
14
Kelaiditi E, van Kan GA, Cesari M. Frailty: role of nutrition and exercise [J]. Curr Opin Clin Nutr Metab Care, 2014, 17(1): 32-39.
[1] 吴越廷, 周林雨涵, 胡钦, 许华燕, 黄敏, 陈晓勇, 张萌, 李中会, 茹凉, 王秋, 蔡晓唐. 皮质类固醇治疗非卧床杜氏肌营养不良症患儿肺功能与运动功能的纵向研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 292-301.
[2] 沈琪乐, 赵勤华, 宫素岗, 刘锦铭, 王岚, 邱宏玲. COPD 稳定期患者血清CC16 蛋白表达与肺功能、肺气肿表型的关系分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 690-695.
[3] 杨莎莎, 张毛为, 孙宜田, 刘亚南, 位娟, 魏建, 陈碧. 结缔组织疾病相关间质性肺病并发小气道功能障碍临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 738-743.
[4] 郭璟琪, 魏明言, 刘芳, 李冬凌, 关金平, 李立华. 乙酰半胱氨酸治疗慢性阻塞性肺疾病急性加重期的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 768-772.
[5] 刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[6] 张璇, 高杨, 房雅君, 姚艳玲. 保护性机械通气在肺癌胸腔镜肺段切除术中的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 563-567.
[7] 陈冬丽, 邓迎丽, 毕婧. α-干扰素治疗急性呼吸道病毒感染对Th1/Th2平衡及肺功能的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 590-594.
[8] 王微, 丁霖, 陈茜, 呼延欣, 闫蓓. 综合治疗对慢性阻塞性肺疾病的疗效及转归影响分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 621-624.
[9] 周璇, 谢莉, 邹娟. 尼达尼布对特发性肺纤维化肺功能、肺纤维化程度及PDGF、PGE2、TGF-β1的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 368-372.
[10] 袁广琴, 朱珠, 林云霞. 胸腺肽联合无创正压通气救治AECOPD并发Ⅱ型呼吸衰竭患者的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 438-441.
[11] 罗孝平, 封敏, 黄川, 唐茜, 蒋艳, 胡莉丽. 渐进式抗阻训练干预在非小细胞肺癌中的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 472-474.
[12] 陈先志, 许磊, 冯其柱, 王琦. 布地奈德联合复方异丙托溴铵雾化吸入在老年患者腹腔镜围手术期中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 531-536.
[13] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[14] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
[15] 何秀, 敖的, 杨郑, 林小华. 改良呼吸支持策略对慢性阻塞性肺疾病急性加重合并Ⅱ型呼吸衰竭患者的疗效[J/OL]. 中华卫生应急电子杂志, 2024, 10(03): 140-144.
阅读次数
全文


摘要